Orbimed Advisors LLC Ironwood Pharmaceuticals Inc Call Options Transaction History

Orbimed Advisors LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2018 May 15, 2018	SELL	$11.13 - $13.63 $2.78 Million - $3.41 Million	-250,000 Reduced 62.5%	150,000 $2.32 Million
Q4 2017 Feb 14, 2018	BUY	$12.16 - $14.58 $4.86 Million - $5.83 Million	400,000	400,000 $6 Million

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.